Author:
Mohapatra L,Bhattamisra S. K,Panigrahy R. C,Parida S.,
Abstract
This study evaluated the antioxidant, hypoglycemic, antidiabetic and alpha amylase inhibiting activities of Sargassum wightii. Antioxidant activity of ethyl acetate and methanol extracts of this seaweed was evaluated and extract having promising antioxidant activity was further studied for hypoglycaemic and antidiabetic activity in normal and alloxan induced diabetic mice, respectively, at 100 and 200mg/ kg after toxicity evaluation. Ethyl acetate extract of S. wightii (EAS) has shown promising antioxidant, hypoglycemic and antidiabetic activity. Total phenol content for EAS was 250.09 ± 4.41mg/g. Fasting plasma glucose level in normal mice was significantly (p<0.05) decreased after 6 days of EAS (200mg/ kg) treatment. EAS at 100 and 200mg/kg has significantly (p<0.05) attenuated AUC of OGTT of diabetic mice. EAS was also found to have potent in vitro alpha-amylase inhibiting property. The current findings suggest that the anti-diabetic activity of S. wightii might be due to its underlying antioxidant, hypoglycemic and alpha-amylase inhibiting property.
Publisher
Indian Drug Manufacturers' Association (IDMA)
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference53 articles.
1. 1. O’Rahilly, S., Barroso, I., Wareham, N.J. Genetic factors in type 2 diabetes, the end of the beginning? Science, 2005; 307: 370-73.
2. 2. Tiwari, A.K., Rao, J.M. Diabetes mellitus and multiple therapeutic approaches of phytochemicals, Present status and future prospects. Curr. Sci., 2002; 83: 30-8.
3. 3. Pandey, A., Tripathi, P., Pandey, R., Srivastava, R., Goswami, S. Alternative therapies useful in the management of diabetes: a systematic review. J. Pharm. Bioallied Sci., 2011; 3: 504-12.
4. 4. Kijjoa, A., Sawangwong, P. Drugs and cosmetics from sea. Mar. Drugs, 2004; 2: 73-82.
5. 5. Boopathy, N.S., Kathiresan, K. Anticancer drugs from marine flora: An overview. J. Oncol., 2010; Article ID 214186: 1-18.